Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.
Crickx E, Chappert P, Sokal A, Weller S, Azzaoui I, Vandenberghe A, Bonnard G, Rossi G, Fadeev T, Storck S, Fadlallah J, Meignin V, Rivière E, Audia S, Godeau B, Michel M, Weill JC, Reynaud CA, Mahévas M.
Crickx E, et al. Among authors: bonnard g.
Sci Transl Med. 2021 Apr 14;13(589):eabc3961. doi: 10.1126/scitranslmed.abc3961.
Sci Transl Med. 2021.
PMID: 33853929
Free PMC article.